Abbildung 15: Telmisartan - Arterienelastizität
In this study, 24 patients with hypertension received telmisartan 40 mg/day for 3 months.1 Brachial-ankle pulse wave velocity (ba-PWV) was significantly reduced. Office blood pressure was also reduced. However, the improvement in ba-PWV was greater than predicted on the basis of blood pressure changes. 1. Uchida H, et al. Practical efficacy of telmisartan for decreasing morning home blood pressure and pulse wave velocity in patients with mild-to-moderate hypertension. Hypertens Res 2004; 27: 545–550.